JP2024543981A5 - - Google Patents
Info
- Publication number
- JP2024543981A5 JP2024543981A5 JP2024532553A JP2024532553A JP2024543981A5 JP 2024543981 A5 JP2024543981 A5 JP 2024543981A5 JP 2024532553 A JP2024532553 A JP 2024532553A JP 2024532553 A JP2024532553 A JP 2024532553A JP 2024543981 A5 JP2024543981 A5 JP 2024543981A5
- Authority
- JP
- Japan
- Prior art keywords
- syndrome
- disease
- autoimmune
- chronic
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306677.2 | 2021-12-01 | ||
| EP21306677 | 2021-12-01 | ||
| PCT/EP2022/083902 WO2023099589A1 (en) | 2021-12-01 | 2022-11-30 | Irap inhibitors for use in the treatment of inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543981A JP2024543981A (ja) | 2024-11-26 |
| JP2024543981A5 true JP2024543981A5 (https=) | 2025-09-17 |
Family
ID=78851081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532553A Pending JP2024543981A (ja) | 2021-12-01 | 2022-11-30 | 炎症性疾患の処置に使用するためのｉｒａｐアミノペプチダーゼ阻害剤の使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250011792A1 (https=) |
| EP (1) | EP4440570A1 (https=) |
| JP (1) | JP2024543981A (https=) |
| WO (1) | WO2023099589A1 (https=) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0599514A3 (en) * | 1992-11-18 | 1994-07-06 | Lilly Industries Ltd | Pyranoquinoline derivatives as inhibitors of cell proliferation. |
| WO1998005624A1 (en) | 1996-08-06 | 1998-02-12 | Taisho Pharmaceutical Co., Ltd. | Amino compounds and angiotensin iv receptor agonists |
| US6566131B1 (en) | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of Smad6 expression |
| AU5901199A (en) | 1998-08-26 | 2000-03-21 | Trustees Of Boston University | Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| US6410323B1 (en) | 1999-08-31 | 2002-06-25 | Isis Pharmaceuticals, Inc. | Antisense modulation of human Rho family gene expression |
| US6107091A (en) | 1998-12-03 | 2000-08-22 | Isis Pharmaceuticals Inc. | Antisense inhibition of G-alpha-16 expression |
| US5981732A (en) | 1998-12-04 | 1999-11-09 | Isis Pharmaceuticals Inc. | Antisense modulation of G-alpha-13 expression |
| US6046321A (en) | 1999-04-09 | 2000-04-04 | Isis Pharmaceuticals Inc. | Antisense modulation of G-alpha-i1 expression |
| US6365354B1 (en) | 2000-07-31 | 2002-04-02 | Isis Pharmaceuticals, Inc. | Antisense modulation of lysophospholipase I expression |
| WO2002016428A1 (fr) | 2000-08-21 | 2002-02-28 | Takeda Chemical Industries, Ltd. | Proteine de liaison a l'irap |
| US6566135B1 (en) | 2000-10-04 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of caspase 6 expression |
| US20050020519A1 (en) | 2001-08-02 | 2005-01-27 | Albiston Anthony L. | Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| CA2518398A1 (en) * | 2003-03-10 | 2004-09-23 | Schering Corporation | Heterocyclic kinase inhibitors: methods of use and synthesis |
| ES2403340T3 (es) | 2004-09-09 | 2013-05-17 | Howard Florey Institute Of Experimental Physiology And Medicine | Inhibidores de aminopeptidasa regulada por insulina (IRAP) y usos de los mismos |
| EP2262797A4 (en) | 2007-11-19 | 2011-11-30 | Howard Florey Inst | INHIBITORS OF INSULIN REGULATED AMINO PEPTIDASE (IRAP) AND APPLICATIONS THEREOF |
| FR2933411B1 (fr) | 2008-07-04 | 2013-04-19 | Univ Joseph Fourier | Utilisation de la proteine irap pour la mise en oeuvre de methodes de diagnostic et de pronostique |
| JP2018527330A (ja) * | 2015-07-30 | 2018-09-20 | モナシュ ユニバーシティー | 線維症の処置 |
-
2022
- 2022-11-30 WO PCT/EP2022/083902 patent/WO2023099589A1/en not_active Ceased
- 2022-11-30 US US18/709,695 patent/US20250011792A1/en active Pending
- 2022-11-30 EP EP22826074.1A patent/EP4440570A1/en active Pending
- 2022-11-30 JP JP2024532553A patent/JP2024543981A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6059255B2 (ja) | ウイルス感染の処置における使用のためのテノホビルアラフェンアミドヘミフマル酸塩とコビシスタットを含む併用療法 | |
| JP2023508142A5 (https=) | ||
| TWI693224B (zh) | 多環胺甲醯基吡啶酮化合物及其醫藥用途 | |
| AU2006203828B2 (en) | CXCR4 antagonists for the treatment of medical disorders | |
| JP2013527144A5 (https=) | ||
| KR960033454A (ko) | 신경원성 질병 및 다른 질병의 치료를 위한 피라졸로피리미딘 및 피롤로피리미딘 | |
| JP2005528443A5 (https=) | ||
| JP2021534106A5 (https=) | ||
| JP2022530985A5 (https=) | ||
| JP2007531740A5 (https=) | ||
| JP2010512342A5 (https=) | ||
| JP2017526675A5 (https=) | ||
| RU2005103226A (ru) | Новые соединения, составы и способы лечения воспалительных заболеваний и состояний | |
| RU2010129027A (ru) | Соединения, обладающие активностью антагонистов crth2 | |
| JP2015526064A5 (https=) | ||
| JP2014534263A5 (https=) | ||
| RU2014125220A (ru) | Белки, связывающие интерлейкин-1 | |
| JP2022531906A5 (https=) | ||
| JP2021530513A5 (https=) | ||
| JP2007519742A5 (https=) | ||
| JPH0422889B2 (https=) | ||
| JP2024543981A5 (https=) | ||
| JP2022549601A5 (https=) | ||
| JP2021530488A5 (https=) | ||
| US6051578A (en) | Pyrazolopyrimidines for treatment of CNS disorders |